Skip to main content
. 2012 May;191(1):107–118. doi: 10.1534/genetics.111.136549

Figure 4 .

Figure 4 

Growth in YPD vs. YPD + 2 μg/ml tunicamycin. (A) Generation time of BY4742 in tunicamycin is ∼2.5-fold greater than in YPD. (B) Cells lacking RPL23A are more severely affected by tunicamycin treatment than cells lacking RPL23B. (C) Cells lacking RPL16A are more severely affected by tunicamycin treatment than cells lacking RPL16B. (D) Cells lacking RPS6A or RPS6B respond similarly to tunicamycin treatment. See also Table S2.